摘要 |
<p>Provided is a novel compound or a pharmaceutically acceptable salt thereof, which is useful for preventing or treating diseases attributed to glycine uptake inhibitory activity such as schizophrenia, Alzheimer's disease, cognitive impairment, dementia, anxiety disorders (such as generalized anxiety disorders, panic disorders, obsessive-compulsive disorders, social anxiety disorders, post-traumatic stress disorders, specific phobia, and acute stress disorders), depression, drug dependence, convulsion, tremor, and sleep disorders. The compound is represented by formula [I].</p> |
申请人 |
TAISHO PHARMACEUTICAL CO., LTD.;YASUHARA, AKITO;YAMAMOTO, SHUJI;OHTA, HIROSHI;SHIRASAKI, YOSHIHISA;SAKAGAMI, KAZUNARI;HAYASHI, MASATO;SHIBATA, TSUYOSHI;SHIMAZAKI, YOUICHI;ARAKI, YUKO;ABE, KUMI;SUN, XIANG-MIN |
发明人 |
YASUHARA, AKITO;YAMAMOTO, SHUJI;OHTA, HIROSHI;SHIRASAKI, YOSHIHISA;SAKAGAMI, KAZUNARI;HAYASHI, MASATO;SHIBATA, TSUYOSHI;SHIMAZAKI, YOUICHI;ARAKI, YUKO;ABE, KUMI;SUN, XIANG-MIN |